Applied Nutrition has announced plans for an initial public offering (IPO) in London, targeting a maximum valuation of £400 million.
- The company’s IPO price range is set between 136 pence and 160 pence per share, indicating a valuation between £340 million and £400 million.
- This move is seen as a positive development for London’s financial market, which has been sluggish recently.
- The IPO will involve up to 137.4 million shares being sold by current shareholders.
- Four notable British entrepreneurs, including Asda co-owner Mohsin Issa, are backing the IPO with a commitment of up to £25 million.
Liverpool-based energy drink manufacturer Applied Nutrition is preparing for a significant financial milestone with its upcoming initial public offering (IPO) in London. The company aims to achieve a valuation of up to £400 million, reflecting a strong market position in the energy drink sector with its Body Fuel branded products.
The IPO price has been strategically set between 136 pence and 160 pence per share. This price range suggests that the company is valued between £340 million and £400 million, highlighting investor confidence in its growth prospects.
This IPO is particularly noteworthy as it signifies a much-needed boost for London’s financial sector, which has faced challenges in attracting new listings. By offering up to 137.4 million shares from existing shareholders, Applied Nutrition is poised to attract substantial investor interest.
An interesting aspect of this offering is the support from four prominent British entrepreneurs. Among them is Mohsin Issa, the co-owner of Asda, who has committed to participate for up to £25 million. This backing serves as a testament to the company’s robust business model and growth trajectory. However, the identity of the other three investors remains undisclosed.
Thomas Ryder, the founder and CEO of Applied Nutrition, holds the majority of the company’s shares. His leadership continues to be a driving force behind the company’s ambitious plans for expansion and market penetration.
The IPO of Applied Nutrition represents a pivotal development for both the company and London’s financial market.
